| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 157, Issue 3 978-983, Copyright © 1996 by American Association of Immunologists
CUTTING EDGE |
DJ Morgan, R Liblau, B Scott, S Fleck, HO McDevitt, N Sarvetnick, D Lo and LA Sherman
Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Transgenic mice that express the influenza virus hemagglutinin (HA) on pancreatic islet beta cells (ins-HA) demonstrate tolerance of HA even after immunization with influenza virus. Surprisingly, when Ins-HA mice were mated with a transgenic mouse expressing a TCR specific for an epitope of HA that is restricted by MHC class I H-2Kd (Clone-4 TCR), the resulting double transgenic (Ins-HA x Clone-4 TCR)F1 neonates developed spontaneous autoimmune diabetes immediately after birth and died within 10 days. This represents a unique situation in which all safeguards within the immune system that normally maintain tolerance of self-antigens in the neonate are insufficient.
This article has been cited by other articles:
|
|
 |
|
  C. N. Janicki, S. R. Jenkinson, N. A. Williams, and D. J. Morgan Loss of CTL Function among High-Avidity Tumor-Specific CD8+ T Cells following Tumor Infiltration Cancer Res., April 15, 2008; 68(8): 2993 - 3000. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. L. Redmond, C.-H. Wei, H. T. C. Kreuwel, and L. A. Sherman The Apoptotic Pathway Contributing to the Deletion of Naive CD8 T Cells during the Induction of Peripheral Tolerance to a Cross-Presented Self-Antigen J. Immunol., April 15, 2008; 180(8): 5275 - 5282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Wallet, P. Sen, R. R. Flores, Y. Wang, Z. Yi, Y. Huang, C. E. Mathews, H. S. Earp, G. Matsushima, B. Wang, et al. MerTK is required for apoptotic cell-induced T cell tolerance J. Exp. Med., January 21, 2008; 205(1): 219 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. VanOosten and T. S. Griffith Activation of Tumor-Specific CD8+ T Cells after Intratumoral Ad5-TRAIL/CpG Oligodeoxynucleotide Combination Therapy Cancer Res., December 15, 2007; 67(24): 11980 - 11990. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Hansen, A. M. Westendorf, S. Reinwald, D. Bruder, S. Deppenmeier, L. Groebe, M. Probst-Kepper, A. D. Gruber, R. Geffers, and J. Buer Chronic Antigen Stimulation In Vivo Induces a Distinct Population of Antigen-Specific Foxp3 CD25 Regulatory T Cells J. Immunol., December 15, 2007; 179(12): 8059 - 8068. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Novy, M. Quigley, X. Huang, and Y. Yang CD4 T Cells Are Required for CD8 T Cell Survival during Both Primary and Memory Recall Responses J. Immunol., December 15, 2007; 179(12): 8243 - 8251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Young, N. S. Wilson, P. Schnorrer, A. Mount, R. J. Lundie, N. L. La Gruta, B. S. Crabb, G. T. Belz, W. R. Heath, and J. A. Villadangos Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens PNAS, November 6, 2007; 104(45): 17753 - 17758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. C. Kousis, B. W. Henderson, P. G. Maier, and S. O. Gollnick Photodynamic Therapy Enhancement of Antitumor Immunity Is Regulated by Neutrophils Cancer Res., November 1, 2007; 67(21): 10501 - 10510. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Quigley, X. Huang, and Y. Yang Extent of Stimulation Controls the Formation of Memory CD8 T Cells J. Immunol., November 1, 2007; 179(9): 5768 - 5777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Bunt, L. Yang, P. Sinha, V. K. Clements, J. Leips, and S. Ostrand-Rosenberg Reduced Inflammation in the Tumor Microenvironment Delays the Accumulation of Myeloid-Derived Suppressor Cells and Limits Tumor Progression Cancer Res., October 15, 2007; 67(20): 10019 - 10026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Galea, M. Bernardes-Silva, P. A. Forse, N. van Rooijen, R. S. Liblau, and V. H. Perry An antigen-specific pathway for CD8 T cells across the blood-brain barrier J. Exp. Med., September 3, 2007; 204(9): 2023 - 2030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. E. Raveney and D. J. Morgan Dynamic Control of Self-Specific CD8+ T Cell Responses via a Combination of Signals Mediated by Dendritic Cells J. Immunol., September 1, 2007; 179(5): 2870 - 2879. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. V. Goldberg, C. H. Maris, E. L. Hipkiss, A. S. Flies, L. Zhen, R. M. Tuder, J. F. Grosso, T. J. Harris, D. Getnet, K. A. Whartenby, et al. Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells Blood, July 1, 2007; 110(1): 186 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Jelley-Gibbs, J. P. Dibble, D. M. Brown, T. M. Strutt, K. K. McKinstry, and S. L. Swain Persistent Depots of Influenza Antigen Fail To Induce a Cytotoxic CD8 T Cell Response J. Immunol., June 15, 2007; 178(12): 7563 - 7570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Guo, M. Dose, D. Kovalovsky, R. Chang, J. O'Neil, A. T. Look, H. von Boehmer, K. Khazaie, and F. Gounari {beta}-Catenin stabilization stalls the transition from double-positive to single-positive stage and predisposes thymocytes to malignant transformation Blood, June 15, 2007; 109(12): 5463 - 5472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Morimoto, X. Tan, R. M. Teague, C. Ohlen, and P. D. Greenberg Induction of Tolerance in CD8+ T Cells to a Transgenic Autoantigen Expressed in the Liver Does Not Require Cross-Presentation J. Immunol., June 1, 2007; 178(11): 6849 - 6860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Sinha, V. K. Clements, A. M. Fulton, and S. Ostrand-Rosenberg Prostaglandin E2 Promotes Tumor Progression by Inducing Myeloid-Derived Suppressor Cells Cancer Res., May 1, 2007; 67(9): 4507 - 4513. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Rudge, S. P. Barrett, B. Scott, and I. R. van Driel Infiltration of a Mesothelioma by IFN-{gamma}-Producing Cells and Tumor Rejection after Depletion of Regulatory T Cells J. Immunol., April 1, 2007; 178(7): 4089 - 4096. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Dobrzanski, J. B. Reome, J. C. Hylind, and K. A. Rewers-Felkins CD8-Mediated Type 1 Antitumor Responses Selectively Modulate Endogenous Differentiated and Nondifferentiated T Cell Localization, Activation, and Function in Progressive Breast Cancer J. Immunol., December 1, 2006; 177(11): 8191 - 8201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yoshino, H. Yamazaki, L. D. Shultz, and S.-I. Hayashi Constant rate of steady-state self-antigen trafficking from skin to regional lymph nodes Int. Immunol., November 1, 2006; 18(11): 1541 - 1548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D McKenzie, N. L Dudek, L. Mariana, M. M. Chong, J. A Trapani, T. W. Kay, and H. E Thomas Perforin and Fas induced by IFN{gamma} and TNF{alpha} mediate beta cell death by OT-I CTL Int. Immunol., June 1, 2006; 18(6): 837 - 846. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Bunt, P. Sinha, V. K. Clements, J. Leips, and S. Ostrand-Rosenberg Inflammation Induces Myeloid-Derived Suppressor Cells that Facilitate Tumor Progression J. Immunol., January 1, 2006; 176(1): 284 - 290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Byersdorfer, G. G. Schweitzer, and E. R. Unanue Diabetes Is Predicted by the {beta} Cell Level of Autoantigen J. Immunol., October 1, 2005; 175(7): 4347 - 4354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Griseri, L. Beaudoin, J. Novak, L. T. Mars, F. Lepault, R. Liblau, and A. Lehuen Invariant NKT Cells Exacerbate Type 1 Diabetes Induced by CD8 T Cells J. Immunol., August 15, 2005; 175(4): 2091 - 2101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Martinez, H. T. C. Kreuwel, W. L. Redmond, R. Trenney, K. Hunter, H. Rosen, N. Sarvetnick, L. S. Wicker, and L. A. Sherman CD8+ T Cell Tolerance in Nonobese Diabetic Mice Is Restored by Insulin-Dependent Diabetes Resistance Alleles J. Immunol., August 1, 2005; 175(3): 1677 - 1685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shin, K. Yoshimura, T. Shin, E. B. Crafton, H. Tsuchiya, F. Housseau, H. Koseki, R. D. Schulick, L. Chen, and D. M. Pardoll In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses J. Exp. Med., May 16, 2005; 201(10): 1531 - 1541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Jenkinson, N. A. Williams, and D. J. Morgan The Role of Intercellular Adhesion Molecule-1/LFA-1 Interactions in the Generation of Tumor-Specific CD8+ T Cell Responses J. Immunol., March 15, 2005; 174(6): 3401 - 3407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Lyman, C. T. Nugent, K. L. Marquardt, J. A. Biggs, E. G. Pamer, and L. A. Sherman The Fate of Low Affinity Tumor-Specific CD8+ T Cells in Tumor-Bearing Mice J. Immunol., March 1, 2005; 174(5): 2563 - 2572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. L. Redmond, B. C. Marincek, and L. A. Sherman Distinct Requirements for Deletion versus Anergy during CD8 T Cell Peripheral Tolerance In Vivo J. Immunol., February 15, 2005; 174(4): 2046 - 2053. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Sinha, V. K. Clements, and S. Ostrand-Rosenberg Reduction of Myeloid-Derived Suppressor Cells and Induction of M1 Macrophages Facilitate the Rejection of Established Metastatic Disease J. Immunol., January 15, 2005; 174(2): 636 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-L. Chen, M. J. Pittet, L. Gorelik, R. A. Flavell, R. Weissleder, H. von Boehmer, and K. Khazaie Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-{beta} signals in vivo PNAS, January 11, 2005; 102(2): 419 - 424. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Zhou, Z. Lu, J. D. McCadden, H. I. Levitsky, and A. L. Marson Reciprocal Changes in Tumor Antigenicity and Antigen-specific T Cell Function during Tumor Progression J. Exp. Med., December 20, 2004; 200(12): 1581 - 1592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Stumbles, R. Himbeck, J. A. Frelinger, E. J. Collins, R. A. Lake, and B. W. S. Robinson Cutting Edge: Tumor-Specific CTL Are Constitutively Cross-Armed in Draining Lymph Nodes and Transiently Disseminate to Mediate Tumor Regression following Systemic CD40 Activation J. Immunol., November 15, 2004; 173(10): 5923 - 5928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Kemp, T. J. Powell, D. W. Dwyer, and R. W. Dutton Cutting Edge: Regulation of CD8+ T Cell Effector Population Size J. Immunol., September 1, 2004; 173(5): 2923 - 2927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. W. Lawrence and T. J. Braciale Activation, Differentiation, and Migration of Naive Virus-Specific CD8+ T Cells during Pulmonary Influenza Virus Infection J. Immunol., July 15, 2004; 173(2): 1209 - 1218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Lyman, S. Aung, J. A. Biggs, and L. A. Sherman A Spontaneously Arising Pancreatic Tumor Does Not Promote the Differentiation of Naive CD8+ T Lymphocytes into Effector CTL J. Immunol., June 1, 2004; 172(11): 6558 - 6567. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. H. Doody, J. T. Kovalchin, M. A. Mihalyo, A. T. Hagymasi, C. G. Drake, and A. J. Adler Glycoprotein 96 Can Chaperone Both MHC Class I- and Class II-Restricted Epitopes for In Vivo Presentation, but Selectively Primes CD8+ T Cell Effector Function J. Immunol., May 15, 2004; 172(10): 6087 - 6092. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hartemann-Heurtier, L. T. Mars, N. Bercovici, S. Desbois, C. Cambouris, E. Piaggio, J. Zappulla, A. Saoudi, and R. S. Liblau An Altered Self-Peptide with Superagonist Activity Blocks a CD8-Mediated Mouse Model of Type 1 Diabetes J. Immunol., January 15, 2004; 172(2): 915 - 922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Morgan, C. T. Nugent, B. J. E. Raveney, and L. A. Sherman In a Transgenic Model of Spontaneous Autoimmune Diabetes, Expression of a Protective Class II MHC Molecule Results in Thymic Deletion of Diabetogenic CD8+ T Cells J. Immunol., January 15, 2004; 172(2): 1000 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. L. Redmond, J. Hernandez, and L. A. Sherman Deletion of Naive CD8 T Cells Requires Persistent Antigen and Is Not Programmed by an Initial Signal from the Tolerogenic APC J. Immunol., December 15, 2003; 171(12): 6349 - 6354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Nowak, B. W. S. Robinson, and R. A. Lake Synergy between Chemotherapy and Immunotherapy in the Treatment of Established Murine Solid Tumors Cancer Res., August 1, 2003; 63(15): 4490 - 4496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. R. Hafalla, A. Morrot, G.-i. Sano, G. Milon, J. J. Lafaille, and F. Zavala Early Self-Regulatory Mechanisms Control the Magnitude of CD8+ T Cell Responses Against Liver Stages of Murine Malaria J. Immunol., July 15, 2003; 171(2): 964 - 970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Nowak, R. A. Lake, A. L. Marzo, B. Scott, W. R. Heath, E. J. Collins, J. A. Frelinger, and B. W. S. Robinson Induction of Tumor Cell Apoptosis In Vivo Increases Tumor Antigen Cross-Presentation, Cross-Priming Rather than Cross-Tolerizing Host Tumor-Specific CD8 T Cells J. Immunol., May 15, 2003; 170(10): 4905 - 4913. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-T. Huang, D. L. Huso, Z. Lu, T. Wang, G. Zhou, E. P. Kennedy, C. G. Drake, D. J. Morgan, L. A. Sherman, A. D. Higgins, et al. CD4+ T Cells Pass Through an Effector Phase During the Process of In Vivo Tolerance Induction J. Immunol., April 15, 2003; 170(8): 3945 - 3953. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Sen, S. Bhattacharyya, M. Wallet, C. P. Wong, B. Poligone, M. Sen, A. S. Baldwin Jr., and R. Tisch NF-{kappa}B Hyperactivation Has Differential Effects on the APC Function of Nonobese Diabetic Mouse Macrophages J. Immunol., February 15, 2003; 170(4): 1770 - 1780. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. de Jersey, D. Carmignac, T. Barthlott, I. Robinson, and B. Stockinger Activation of CD8 T Cells by Antigen Expressed in the Pituitary Gland J. Immunol., December 15, 2002; 169(12): 6753 - 6759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. McGargill, D. Mayerova, H. E. Stefanski, B. Koehn, E. A. Parke, S. C. Jameson, A. Panoskaltsis-Mortari, and K. A. Hogquist A Spontaneous CD8 T Cell-Dependent Autoimmune Disease to an Antigen Expressed Under the Human Keratin 14 Promoter J. Immunol., August 15, 2002; 169(4): 2141 - 2147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hernandez, S. Aung, K. Marquardt, and L. A. Sherman Uncoupling of Proliferative Potential and Gain of Effector Function by CD8+ T Cells Responding to Self-Antigens J. Exp. Med., August 5, 2002; 196(3): 323 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Nowak, B. W. S. Robinson, and R. A. Lake Gemcitabine Exerts a Selective Effect on the Humoral Immune Response: Implications for Combination Chemo-immunotherapy Cancer Res., April 1, 2002; 62(8): 2353 - 2358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Poligone, D. J. Weaver Jr., P. Sen, A. S. Baldwin Jr., and R. Tisch Elevated NF-{kappa}B Activation in Nonobese Diabetic Mouse Dendritic Cells Results in Enhanced APC Function J. Immunol., January 1, 2002; 168(1): 188 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. von Herrath, T. Wolfe, U. Mohrle, B. Coon, and A. Hughes Protection From Type 1 Diabetes in the Face of High Levels of Activated Autoaggressive Lymphocytes in a Viral Transgenic Mouse Model Crossed to the SV129 Strain Diabetes, December 1, 2001; 50(12): 2700 - 2708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Cornet, T. C. Savidge, J. Cabarrocas, W.-L. Deng, J.-F. Colombel, H. Lassmann, P. Desreumaux, and R. S. Liblau Enterocolitis induced by autoimmune targeting of enteric glial cells: A possible mechanism in Crohn's disease? PNAS, October 25, 2001; (2001) 231474098. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hernandez, S. Aung, W. L. Redmond, and L. A. Sherman Phenotypic and Functional Analysis of CD8+ T Cells Undergoing Peripheral Deletion in Response to Cross-Presentation of Self-Antigen J. Exp. Med., September 10, 2001; 194(6): 707 - 718. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Usherwood, K. A. Ward, M. A. Blackman, J. P. Stewart, and D. L. Woodland Latent Antigen Vaccination in a Model Gammaherpesvirus Infection J. Virol., September 1, 2001; 75(17): 8283 - 8288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Ludewig, K. McCoy, M. Pericin, A. F. Ochsenbein, T. Dumrese, B. Odermatt, R. E. M. Toes, C. J. M. Melief, H. Hengartner, and R. M. Zinkernagel Rapid Peptide Turnover and Inefficient Presentation of Exogenous Antigen Critically Limit the Activation of Self-Reactive CTL by Dendritic Cells J. Immunol., March 15, 2001; 166(6): 3678 - 3687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Pauza, A. Nguyen, T. Wolfe, I-C. Ho, L. H. Glimcher, M. von Herrath, and D. Lo Variable Effects of Transgenic c-Maf on Autoimmune Diabetes Diabetes, January 1, 2001; 50(1): 39 - 46. [Abstract] [Full Text]
|
|
|
|
|
|
A. L. Marzo, B. F. Kinnear, R. A. Lake, J. J. Frelinger, E. J. Collins, B. W. S. Robinson, and B. Scott Tumor-Specific CD4+ T Cells Have a Major ""Post-Licensing"" Role in CTL Mediated Anti-Tumor Immunity J. Immunol., December 1, 2000; 165(11): 6047 - 6055. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Vizler, N. Bercovici, A. Heurtier, N. Pardigon, K. Goude, K. Bailly, C. Combadiere, and R. S. Liblau Relative Diabetogenic Properties of Islet-Specific Tc1 and Tc2 Cells in Immunocompetent Hosts J. Immunol., December 1, 2000; 165(11): 6314 - 6321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Usherwood, D. J. Roy, K. Ward, S. L. Surman, B. M. Dutia, M. A. Blackman, J. P. Stewart, and D. L. Woodland Control of Gammaherpesvirus Latency by Latent Antigen-specific CD8+ T Cells J. Exp. Med., September 25, 2000; 192(7): 943 - 952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Bercovici, A. Heurtier, C. Vizler, N. Pardigon, C. Cambouris, P. Desreumaux, and R. Liblau Systemic Administration of Agonist Peptide Blocks the Progression of Spontaneous CD8-Mediated Autoimmune Diabetes in Transgenic Mice Without Bystander Damage J. Immunol., July 1, 2000; 165(1): 202 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Pardigon, C. Cambouris, N. Bercovici, F. Lemaitre, R. Liblau, and P. Kourilsky Delayed and Separate Costimulation In Vitro Supports the Evidence of a Transient ""Excited"" State of CD8+ T Cells During Activation J. Immunol., May 1, 2000; 164(9): 4493 - 4499. [Abstract] [Full Text] [PDF]
|
|
|
</ |
